Advanced search
Publication Cover
Expert Review of Gastroenterology & Hepatology Volume 12, 2018 - Issue 8
Submit an article Journal homepage
75
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Impact of primary tumor side on the outcomes of patients with non-metastatic colon cancer; a patient-level pooled analysis of two clinical trials

Anwar GiryesComplementary medicine, Swiss medical Clinic, Zurich, SwitzerlandView further author information
,
Hani OweiraSurgery Department, Gastrointestinal Tumor Zentrum, Zürich, SwitzerlandView further author information
,
Meinrad MannhartDepartment of Oncology, Center of Zug, Zug, SwitzerlandView further author information
&
Omar Abdel-RahmanClinical Oncology department, faculty of medicine, Ain shams university, Cairo, Egypt;Department of Oncology, University of Calgary and Tom Baker Cancer center, Calgary, Alberta, CanadaCorrespondence[email protected] [email protected]
ORCID Iconhttp://orcid.org/0000-0002-5117-2502View further author information
ORCID Icon
Pages 843-848 | Received 23 Mar 2018, Accepted 27 Jun 2018, Published online: 10 Jul 2018

References

  • globocan.iarc.fr. [Cited 2016 11 27].
  • Labianca R, Nordlinger B, Beretta GD, et al. Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi64–72.
  • Byun JH, Ahn JB, Kim SY, et al. The impact of primary tumor location in patients with metastatic colorectal cancer: a korean cancer study group CO12-04 study. Korean J Intern Med. 2017.
  • Karim S, Brennan K, Nanji S, et al. Association between prognosis and tumor laterality in early-stage colon cancer. JAMA Oncology. 2017;3(10):1386–1392.
  • Abdel-Rahman O. Challenging a dogma: five-year survival does not equal cure in all colorectal cancer patients. Expert Rev Anticancer Ther. 2018;18(2):187-192.
  • https://www.projectdatasphere.org/projectdatasphere/html/home. [Cited 2017 10 7]
  • Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–2351.
  • Niedzwiecki D, Bertagnolli MM, Warren RS, et al. Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581. J Clin Oncol. 2011;29(23):3146–3152.
  • Ashktorab H, Smoot DT, Carethers JM, et al. High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res. 2003;9(3):1112–1117.
  • Ashktorab H, Smoot DT, Farzanmehr H, et al. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer. 2005;116(6):914–919.
  • Benson AB 3rd, Venook AP, Bekaii-Saab T, et al. Colon cancer, version 3.2014. J Natl Compr Canc Netw. 2014;12(7):1028–1059.
  • Jo WS, Carethers JM. Chemotherapeutic implications in microsatellite unstable colorectal cancer. Cancer Biomark. 2006;2(1–2):51–60.
  • Lee MS, Menter DG, Kopetz S. Right versus left colon cancer biology: integrating the consensus molecular subtypes. J Natl Compr Canc Netw. 2017;15(3):411–419.
  • Warschkow R, Sulz MC, Marti L, et al. Better survival in right-sided versus left-sided stage I - III colon cancer patients. BMC Cancer. 2016;16(1):554.
  • Weiss JM, Pfau PR, O’Connor ES, et al. Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results–medicare data. J Clin Oncol. 2011;29(33):4401–4409.
  • Petrelli F, Tomasello G, Borgonovo K, et al. Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncology. 2017;3(2):211–219.
  • Abdel-Rahman O. Revisiting Dukes’ paradigm; some node positive colon cancer patients have better prognosis than some node negative patients. Clin Transl Oncol. 2018;20(6):794-800.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.